Support Alert

Tecovirimat as a treatment for patients hospitalised due to Monkeypox viral infection

A Chief Medical Officer therapeutic alert has been published regarding Tecovirimat as a treatment for patients hospitalised due to Monkeypox infection.

Tecovirimat is now available to symptomatic patients hospitalised due to a severe or complicated monkeypox infection in line with the published UK interim clinical policy statement. Supply is being managed via specialist regional adult infectious diseases centres.

Further information and actions can be found in the Chief Medical Officer Therapeutic Alert and Clinical Commissioning Rapid Policy Statement: Tecovirimat as treatment for patients hospitalised due to monkeypox virus infection available on the CAS website.

Loading...

A day you'll remember: #RPSConf22

Stageofcareerqualify

On Friday 11 November, we'll change how you think about pharmacy, how you work with colleagues, and how you see yourself and your future!

LISTEN - LEARN - DISCUSS - ENJOY!

Join us and discover how much pharmacy is changing. It’s a day for you to listen, to learn, and to discuss - as well as to enjoy meeting all your fellow professionals.

Get inspired with us on Friday, 11 November, and discover the future of pharmacy.

DON'T MISS OUT